medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2025, Number 4

<< Back Next >>

Ginecol Obstet Mex 2025; 93 (4)

Impact of the COVID-19 on mammography screening in Mexico, Brazil, Uruguay, Peru, and Argentina

Villaseñor NY, Garduño DM, Cadena GOE, Sollozo DI

Language: Spanish
References: 42
Page: 135-151
PDF size: 642.69 Kb.


ABSTRACT

Objective: To present and describe the effects of COVID-19 on breast cancer screening in Latin America, and to propose an alternative solution to address the delays in timely breast cancer detection in the region.
Methodology: A search for information was conducted on four databases [Pubmed/ Medline, Scopus, Cochrane Library, LILACS] to identify studies on the impact of COYolanda VID-19 on timely breast cancer detection activities, with a focus on the detriment suffered by these activities. Systematic reviews and randomized controlled trials written in Spanish, English, or Portuguese, published between January 2020 and August 2023, were included. The search employed DeCS and MeSH controlled vocabulary terms in various interfaces, yielding 113 articles, of which 10 met the inclusion criteria. A descriptive and narrative approach was used to present the search results.
Results: Ten studies were included in this narrative review, with two exhibiting high bias. A reduction in breast cancer screening volumes of over 40% was detected in more than half of the studies, from the declaration of the health emergency until December 2020. However, during the peak period of the pandemic, from April to June, the recorded deficit reached 70%. Some articles reported the population studied rate, a crucial aspect given that Latin American countries follow an opportunistic screening approach, making the obtained data "relative."
Conclusions: Evidence is presented regarding a significant reduction in timely breast cancer detection activities in Latin America. However, these findings stem from short periods and opportunistic breast cancer screening programs. It is essential to expand the information on timely breast cancer detection during the pandemic to obtain reliable evidence of the impact left in this regard.


REFERENCES

  1. Huenchuan S, del Castillo M. Desigualdad en Centroamérica, México y el Caribe: análisis de brechas y recomendaciones. Repositorio Digital Beta. Comisión Económica paraAmérica Latina y el Caribe. https://repositorio.cepal.org/items/8b642137-f52e-4948-94d7-bb05453458b3

  2. Instituto Nacional de Salud. COVID-19: progreso de lapandemia y sus desigualdades en Colombia; Décimotercer Informe Técnico. 2021 Observatorio Nacionalde Salud. https://www.ins.gov.co/Direcciones/ONS/Informes/13.%20COVID-19,%20progreso%20de%20la%20pandemia%20y%20su%20impacto%20en%20las%20desigualdades%20en%20Colombia.pdf

  3. Rocha AFBM, Freitas-Junior R, Ferreira GLR, RodriguesDCN, Rahal RMS. COVID-19 and Breast Cancer in Brazil. IntJ Public Health. 2023; 68: 1605485. https://doi-org.pbidi.unam.mx:2443/10.3389/ijph.2023.1605485

  4. Bonadio RC, Messias AP, Moreira OA, et al. Impact of theCOVID-19 pandemic on breast and cervical cancer stageat diagnosis in Brazil. Ecancermedicalscience 2021; 15:1299. https://doi-org.pbidi.unam.mx:2443/10.3332/ecancer.2021.1299

  5. Kopek J. Cancer & Covid-19: New Challenges to ControllingCancer in Latin America and the Caribbean. The DialogueLeadership for the America. https://www.thedialogue.org/analysis/cancer-covid-19-new-challenges-to-controllingcancer-in-latin-america-and-the-caribbean/

  6. Ruvalcaba-Limón E. ¿Cuánto más podrá dañar la pandemiaen la detección oportuna de cáncer de mama? GacetaMexicana de Oncología 2022; 21(4), 146-148. https://doi.org/24875/j.gamo.M22000221

  7. Li T, Nickel B, Ngo P, et al. A systematic review of the impactof the COVID-19 pandemic on breast cancer screening anddiagnosis. Breast. 2023; 67: 78-88. https://doi-org.pbidi.unam.mx:2443/10.1016/j.breast.2023.01.001

  8. Breast Screening Working Group (WG2) of the Covid-19and Cancer Global Modelling Consortium, Figueroa JD, GrayE, et al. The impact of the Covid-19 pandemic on breastcancer early detection and screening. Prev Med 2021; 151:106585. https://doiorg.pbidi.unam.mx:2443/10.1016/j.ypmed.2021.106585

  9. Instituto Nacional de Estadística y Geografía e Informática.Comunicado de prensa 571/215, 18 de octubre de 2021.Estadísticas a propósito del día mundial de la lucha contra el cáncer de mama (19 de octubre). https://www.inegi.org.mx/contenidos/saladeprensa/aproposito/2021/EAP_LUCHACANCER2021.pdf. (Consulta: septiembre 2023)

  10. Herrera W. Cáncer de mama aumenta en México. Serendipia. https://serendipia.digital/datos-y-mas/cancer-demama-aumenta-en-mexico/

  11. Gobierno de México. Día Mundial de la Lucha Contra elCáncer de Mama. Instituto Nacional de Salud Pública.https://insp.mx/avisos/dia-mundial-de-lucha-contra-elcancer-de-mama.

  12. Arellano S. El Cáncer de mama: una tragedia que puede evitarse. México Social. La cuestión social en México. https://www.mexicosocial.org/el-cancer-de-mama/

  13. Organización Panamericana de la Salud. Salud en lasAméricas 2022. Panorama de la Región de las Américasen el contexto de la pandemia de COVID-19. Pan AmericanHealth Organization. Institutional Repository for Information Sharing. https://iris.paho.org/handle/10665.2/56471

  14. Organización Panamericana de la Salud. Salud en lasAméricas. Panorama de salud. https://hia.paho.org/es/covid-2022/salud

  15. Cruz CH. Mortalidad por COVID-19 y las desigualdades pornivel socioeconómico y por territorio. Naciones UnidasComisión Económica para América Latina y el Caribe.https://www.cepal.org/es/enfoques/mortalidad-covid19-desigualdades-nivel-socioeconomico-territorio

  16. Organización Mundial de la Salud. Comunicado de prensa:Según una encuesta mundial de la OMS, el 90% de lospaíses han sufrido interrupciones de sus servicios de saludesenciales desde el inicio de la pandemia de COVID-19.La OMS pondrá en marcha instrumentos de aprendizajey monitoreo para mejorar la prestación de serviciosdurante una pandemia. OMS. https://www.who.int/es/news/item/31-08-2020-in-who-global-pulse-survey-90-ofcountries-report-disruptions-to-essential-health-servicessince-covid-19-pandemic

  17. Ginexeltis. La Iniciativa Mundial contra el Cáncer de Mamade la OMS https://ginexeltis.mx/noticia/la-iniciativamundial-contra-el-cancer-de-mama-de-la-oms

  18. Funaro MA, Soares OAL. Cuatro recomendaciones parapromover políticas públicas basadas en evidencia. InterAmerican Development Bank: Impacto. https://blogs.iadb.org/efectividad-desarrollo/es/cuatro-recomendacionespara-promover-politicas-publicas-basadas-en-evidencia/

  19. Britannica T. Editors of Encyclopaedia. List of countriesin Latin America. Encyclopedia Britannica. https://www.britannica.com/topic/list-of-countries-in-Latin-America-2061416

  20. Rueda E, Villavicencio S, eds. Modernidad, colonialismoy emancipación en América Latina 1ª edición . BuenosAires: CLACSO, 2018.

  21. Sollozo-Dupont I, Lara-Ameca VJ, Cruz-Castillo D, VillaseñorNavarro Y. Relationship between Health Inequalities andBreast Cancer Survival in Mexican Women. Int J EnvironRes Public Health 2023; 20 (7): 5329. https://doi-org.pbidi.unam.mx:2443/10.3390/ijerph20075329

  22. Vázquez Rosas T, Cazap E, Delgado L, Ismael J, et al. Socialdistancing and economic crisis during COVID-19 pandemicreduced cancer control in Latin America and will result inincreased late-stage diagnoses and expense. JCO GlobOncol 2021; 7: 694-703. https://doi.org.pbidi.unam.mx:2443/10.1200/GO.21.00016

  23. Teglia F, Angelini M, Astolfi L, Casolari G, et al. Global Association of COVID-19 pandemic measures with cancerscreening: a systematic review and meta-analysis. JAMAOncol 2022; 8 (9): 1287-93. https://doi-org.pbidi.unam.mx:2443/10.1001/jamaoncol.2022.2617

  24. Sollozo-Dupont I, Galván-Espinoza HA, Castillo-LópezJP, Benítez-López EO, et al. Impacto de la pandemia deCOVID-19 en el tamizaje de cáncer de mama y algunasestrategias para actuar pronto y seguro. Salud PublicaMex 2022; 64: 333-339. https://doi-org.pbidi.unam.mx:2443/10.21149/13412

  25. Tachibana BMT, Ribeiro RLM, Federicci ÉEF, et al. Thedelay of breast cancer diagnosis during the COVID-19 pandemic in São Paulo, Brazil. Einstein (Sao Paulo) 2021; 19:eAO6721. https://doi.org.pbidi.unam.mx:2443/10.31744/einstein_journal/2021AO6721

  26. Demarchi PKH, Maurer E, Pierini NI, Lammel BL, et al.O Impacto da Pandemia da Covid-19 no Volume de Mamografias no Brasil: uma Análise de Previsão Baseadanos Números Históricos. RBC 2022; 68 (3). https://doi.org/10.32635/2176-9745.RBC.2022v68n3.2566

  27. de Degani GL, Duarte L, Ismael J, Martinez L, et al. Theimpact of the COVID-19 pandemic on cancer care in thepublic health subsector, province of Santa Fe, Argentina.Ecancermedicalscience 2021; 15: 1270. https://doi-org.pbidi.unam.mx:2443/10.3332/ecancer.2021.1270

  28. Negrao EMS, Cabello C, Conz L, Mauad EC, et al. TheCOVID-19 pandemic impact on breast cancer diagnosis: aretrospective study. O impacto da pandemia de COVID-19no diagnóstico de câncer de mama: Um estudo retrospectivo. Rev Bras Ginecol Obstet 2022; 44 (9): 871-77. https://doi-org.pbidi.unam.mx:2443/10.1055/s-0042-1749207

  29. Duarte MBO, Argenton JLP, Carvalheira JBC. Impact ofCOVID-19 in Cervical and Breast Cancer Screening and Systemic Treatment in São Paulo, Brazil: An Interrupted TimeSeries Analysis. JCO Glob Oncol. 2022;8:e2100371. https://doi-org.pbidi.unam.mx:2443/10.1200/GO.21.00371

  30. Bessa JF. Breast imaging hindered during covid-19pandemic, in Brazil. Rev Saude Publica 2021; 55: 8.https://doi-org.pbidi.unam.mx:2443/10.11606/s1518-8787.2021055003375

  31. Ribeiro CM, Correa FM, Migowski A. Short-term effects ofthe COVID-19 pandemic on cancer screening, diagnosisand treatment procedures in Brazil: a descriptive study,2019-2020. Epidemiol Serv Saude 2022; 31 (1): e2021405.https://doi-org.pbidi.unam.mx:2443/10.1590/S1679-49742022000100010

  32. Yong JH, Mainprize JG, Yaffe MJ, et al. The impact of episodic screening interruption: COVID-19 and populationbased cancer screening in Canada. J Med Screen 2021; 28(2): 100-107. https://doi-org.pbidi.unam.mx:2443/10.1177/0969141320974711

  33. Luo Q, O'Connell DL, Yu XQ, et al. Cancer incidence andmortality in Australia from 2020 to 2044 and an exploratoryanalysis of the potential effect of treatment delays duringthe COVID-19 pandemic: a statistical modelling study[published correction appears in Lancet Public Health. 2022Nov;7(11):e895]. Lancet Public Health 2022; 7 (6): e537-e548. https://doi.org/10.1016/S2468-2667(22)00090-1

  34. Naciones Unidas. Dos buques del OIEA navegan por lasaguas del Amazonas para detectar el cáncer de mama. Noticias ONU. [en línea]. Dirección URL: https://news.un.org/es/story/2022/02/1503952. (Consulta: septiembre 2023)

  35. Cairns A, Jones VM, Cronin K, Yocobozzi M, et al. Impactof the COVID-19 Pandemic on Breast Cancer Screeningand Operative Treatment. Am Surg 2022; 88 (6): 1051-53.https://doi-org.pbidi.unam.mx:2443/10.1177/00031348221087920

  36. Chiarelli AM, Walker MJ, Espino-Hernandez G, YocobozziM, et al. Adherence to guidance for prioritizing higher riskgroups for breast cancer screening during the COVID-19pandemic in the Ontario Breast Screening Program: adescriptive study. CMAJ Open 2021; 9 (4): E1205-E1212.https://doi-org.pbidi.unam.mx:2443/10.1177/00031348221087920

  37. Blanco S, Andisco D, Jiménez P, Luciani S. Calidad de lamamografía y tamizaje del cáncer de mama en Argentina.Rev Panam Salud Publica 2019; 43: e63. https://doi-org.pbidi.unam.mx:2443/10.26633/RPSP.2019.63

  38. Mishra GA, Pimple SA, Mittra I, Badwe RA. Screening forbreast cancer: Cost-effective solutions for low- & middleincome countries. Indian J Med Res. 2021; 154 (2): 229-236. https://doi-org.pbidi.unam.mx:2443/10.4103/ijmr.IJMR_2635_20

  39. Ginsburg O, Yip CH, Brooks A, Cabanes A, Caleff, M, DunstanYataco JA, et al. Breast cancer early detection: A phasedapproach to implementation. Cancer 2020;126 (Suppl 10):2379-93. https://doi-org.pbidi.unam.mx:2443/10.1002/cncr.32887

  40. Naciones Unidas. Dos buques del OIEA navegan por lasaguas del Amazonas para detectar el cáncer de mama. Noticias ONU. https://news.un.org/es/story/2022/02/1503952

  41. García AS. Lectura crítica de la evidencia científica. Enfermería en cardiología: revista científica e informativade la Asociación Española de Enfermería en Cardiología.https://enfermeriaencardiologia.com/wp-content/uploads/63_01.pdf

  42. Organización Panamericana de la Salud. OrganizaciónMundial de la Salud. OPS busca prevenir casos de cáncerde mama y cervicouterino que causan 120 mil muertesanuales en las Américas. https://www.paho.org/es/noticias/4-2-2013-ops-busca-prevenir-casos-cancermama-cervicouterino-que-causan-120-mil-muertes




2020     |     www.medigraphic.com